Security Notice: Please be aware of impersonation attempts using our company name
Legitimate communications from Ascent Research will only come from official @ascentresearch.com email addresses.
Quick Order Cart

Cat. No. ARG40569

EEF1E1 Knockout HEK293T Polyclonal Cells

  • Product Type:

    Polyclonal Cell Population

  • Species:

    Homo sapiens (Human)

  • Tissue Source:

    Kidney

The EEF1E1 Knockout HEK293T Polyclonal Cells are a CRISPR/Cas9-edited polyclonal HEK293T cell population with targeted disruption of EEF1E1, a guanine nucleotide exchange factor for eEF1A. EEF1E1 is regulated by mTORC1 and MYC and functions within the eEF1B complex to catalyze GDP?CGTP exchange on eEF1A, thereby promoting translation elongation. This knockout model is ideal for dissecting translational control mechanisms, evaluating elongation factor roles in cancer, and screening for translation inhibitors. Assays such as polysome profiling, puromycin incorporation, and co-immunoprecipitation of the eEF1 complex can be performed to validate functional outcomes.

Inquire Now

In stock

Ships next business day


Ask a Question

Shipping Info:

Cryopreserved in vials and shipped on dry ice


Disclaimer:

For Research Use Only

  • Characteristics

    Host Cell

    HEK293T

    Sex of Donor

    Female

    Age

    Fetus

    Derived From Site

    Fetal kidney

    Gene Name

    EEF1E1

    Gene Identifier

    NCBI Gene ID 9521

    Growth Mode

    Adherent

    Storage

    Liquid nitrogen (LN2)

  • Culture Conditions

    Growth medium

    DMEM

    Supplement(s)

    10% Fetal Bovine Serum, 1% Penicillin-Streptomycin Solution

    Temperature

    37°C

    Atmosphere

    5% CO₂

  • Quality Control

    Sterility testing

    The bacterial, yeast, and fungi are not detected in these cells by daily monitor.

    Mycoplasma testing

    Negative for mycoplasma through PCR analysis

  • Disclaimer

    Intended Use

    This product is intended for laboratory in vitro use only. lt is not intended for diagnostic, therapeutic, or clinical applications.

    Disclaimer

    Ascent Research endeavors to provide accurate and up-to-date product information. However, no warranties or representations are made regarding its completeness or reliability. References to scientific literature and patents are for informational purposes only, and the customer assumes sole responsibility for verifying their accuracy.

    By accepting this product, the customer acknowledges and agrees to assume all risks associated with its receipt, handling, storage, disposal, and use, including compliance with all applicable safety and environmental regulations and precautions. Relevant laws, regulations, and ethical guidelines must be followed in conducting any research, modifications, or derivatives derived from this product.

    This product is provided "AS IS", and except as expressly stated herein, Ascent Research disclaims all other warranties, express or implied. Under no circumstances shall Ascent Research, its affiliates, or representatives be liable for indirect, incidental, consequential, or punitive damages arising from the use of this material. While Ascent Research employs rigorous quality control measures, we shall not be held responsible for damages resulting from misidentification or misinterpretation of the provided materials.

Description

The EEF1E1 Knockout HEK293T Polyclonal Cells product comprises a polyclonal HEK293T cell population engineered via CRISPR/Cas9-mediated gene disruption of the EEF1E1 locus. This knockout model provides a powerful tool for investigating the functional roles of EEF1E1, a guanine nucleotide exchange factor (GEF) essential for translation elongation. By generating a heterogeneous pool of edited cells, this polyclonal format captures a range of allelic disruptions, reflecting the complexity of genetic loss-of-function phenotypes while avoiding clonal selection artifacts.

The host cell line is HEK293T, an adherent epithelial line derived from human embryonic kidney cells transformed with sheared adenovirus type 5 DNA. These cells stably express the SV40 large T-antigen, which enables episomal replication of plasmids containing the SV40 origin, leading to high-level recombinant protein expression and efficient viral production. HEK293T cells are widely employed in basic and translational research due to their robust translational machinery and ease of transient transfection, making them an ideal parental line for studying protein synthesis and its regulatory components.

EEF1E1 encodes a subunit of the eEF1B complex that functions as a GEF for elongation factor 1-alpha (eEF1A). Mechanistically, EEF1E1 catalyzes the exchange of GDP for GTP on eEF1A, a reaction that is stimulated by mTORC1 signaling and transcriptionally regulated by the MYC oncogene. This GTP-bound eEF1A then delivers aminoacyl-tRNA to the ribosomal A-site, promoting peptide chain elongation. EEF1E1 directly interacts with eEF1A and the eEF1B complex components EEF1B2 and EEF1D, and its activity is crucial for maintaining global protein synthesis rates. Disruption of EEF1E1 thus compromises translation elongation efficiency and downstream protein output.

In HEK293T cells, which exhibit exceptionally high translational capacity owing to their viral transformation and SV40 T-antigen-mediated enhancement of host protein synthesis, knockout of EEF1E1 creates a model system to assess the role of elongation factors in sustaining elevated translational output. This polyclonal knockout population allows researchers to examine how loss of EEF1E1 affects polysome profiles, ribosome occupancy, and global translation rates, providing insights into the regulatory nodes controlling protein synthesis under conditions of rapid cell proliferation often associated with cancer.

Typical applications include studying translational control mechanisms, investigating the contributions of elongation factors to oncogenic transformation, and screening for small-molecule translation inhibitors. Researchers can employ a range of assays such as polysome profiling, ribosome profiling, puromycin incorporation-based protein synthesis assays, GTPase activity measurements, co-immunoprecipitation of the eEF1 complex, and RT-qPCR for confirming EEF1E1 disruption. These analyses enable detailed functional dissection of the translation elongation machinery in a genetically tractable cell background. For further technical details or ordering information, please contact Ascent Research.

Reset Password

    Reach Us Questions? Click Me Here!

    Fill out the form below and a member of our team will contact you shortly!

    *Required field



      Reach Us

      Fill out the form below and a member of our team will contact you shortly!

      *Required field

      Product Inquiry (Optional)